Brent A. Johnson, Ph.D.

Registered Patent Attorney Shareholder

Brent A. Johnson, Ph.D.

Office: 949.202.1900

Direct: 949.202.1903

VCard

PDF

Brent A. Johnson, Ph.D.

Registered Patent Attorney Shareholder

Brent Johnson is a shareholder in the firm’s Orange County office. He focuses his practice on intellectual property matters. Areas of practice include patent prosecution, BPAI post grant proceedings, IP due diligence, Import/Export issues related to IP, and client counseling, particularly in the areas of pharmaceutical technologies, medical devices and other chemistry-related technology.

Dr. Johnson manages and procures IP portfolios in the life sciences and other chemistry and material-based technologies. Previously, he was a partner at a large international law firm, and a patent attorney at another high end IP Southern California-based boutique firm. He began his IP career as a patent agent at Allergan, Inc., where he managed patent portfolios for pharmaceutical products representing about $1 billion in annual sales, such as Lumigan®, Alphagan®, Combigan®, Restasis®, and others. Prior to his legal career, Dr. Johnson worked as a research chemist at an LA-based chemical company. He earned a Ph.D. at UCLA, where he studied the influence of quantum mechanical tunneling in a photochemical hydrogen transfer reaction for various ortho-methylarylketones that he synthesized.

  • Education
    • J.D., Whittier Law School
    • Ph.D., University of California, Los Angeles, Chemistry
    • B.S., Brigham Young University, Chemistry
  • Practice Focus
    • IP Procurement and
      Portfolio Management
    • Patent Prosecution
    • Post Grant Proceedings
    • Freedom to operate
    • Due diligence
    • Infringement
    • Validity
    • IP-Related Import/Export
  • Technical Experience
    • Pharmaceuticals
    • Ophthalmics
    • Life Sciences
    • Medical devices
    • Drug delivery systems
    • Prostaglandins
    • Retinoids
    • Alpha adrenergics
    • Cannabinoids
    • Organophosphorous compounds
    • NSAIDS
    • Steroids
    • Cyclodextrins
    • Cyclosporins
    • Opioids
    • Neurotoxins
    • Semiconductors
    • Photocatalysts
    • Light-emitting materials
    • Charge transport materials
    • Ceramics
    • Graphenes
    • Polymers
    • Coatings
    • Adhesives
    • Surfactants
    • Halocarbons
    • Rocket fuels
  • Professional Admissions & Associations
    • United States Patent and Trademark Office
    • California State Bar
    • J. Reuben Clark Law Society
    • American Chemical Society
  • Publications, Speaking Engagements & Presentations
    • “Strategic and Practical Considerations for Accelerated Examination in the United States,” Patent Lawyer Magazine (March/April 2022)
    • “Hey, That’s My Invention! Avoiding Costly Ownership Mistakes With IP,” The Orange County Business Journal (October 1, 2020)
  • Awards & Recognition
    • Patexia Insights – Ranked #13, Best Performing Attorney in Biotech
    • Southern California Super Lawyers Rising Stars (2014-2018)
  • Representative Matters
    • Patent No. 9,309,237 “HIV inhibitors”
    • Patent No. 7,399,868 “4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones Acting as Alpha 2 Adrenergic Agonists”
    • Patent No. 7,323,463 “Combination of Brimonidine and Timolol for Topical Ophthalmic Use”
    • Patent Publication No. 20100213831 “Ambipolar Host In Organic Light Emitting Diode”
    • Patent No. 7,763,341 “Filled Polymer Composite and Synthetic Building Material Composition
    • BioMagic, Inc. v. Dutch Brothers Enterprises – patent license arbitration and patent infringement lawsuit related to odor control compositions

News and Articles

View All Professionals